JPS5817728B2 - Ampicillin Sodium - Google Patents
Ampicillin SodiumInfo
- Publication number
- JPS5817728B2 JPS5817728B2 JP48130502A JP13050273A JPS5817728B2 JP S5817728 B2 JPS5817728 B2 JP S5817728B2 JP 48130502 A JP48130502 A JP 48130502A JP 13050273 A JP13050273 A JP 13050273A JP S5817728 B2 JPS5817728 B2 JP S5817728B2
- Authority
- JP
- Japan
- Prior art keywords
- ampicillin
- methylene chloride
- solution
- sodium salt
- diisopropylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は含水量0.2〜1.0%のアンピシリンジイソ
プロピルアミン塩塩化低級アルキレン溶液と2−エチル
ヘキサン酸ナトリウムとを反応させることを特徴とする
アンピシリンナトリウム塩の製法に関する。Detailed Description of the Invention The present invention provides a method for producing ampicillin sodium salt, which is characterized by reacting a lower alkylene chloride solution of ampicillin diisopropylamine salt having a water content of 0.2 to 1.0% with sodium 2-ethylhexanoate. Regarding.
本発明によって得られるアンピシリンナトリウム塩は高
純度で、かつ水溶性が高いので粉末注射薬として用いる
と好適である。Ampicillin sodium salt obtained by the present invention has high purity and high water solubility, so it is suitable for use as a powder injection.
アンピシリンは世界的に汎用されている抗生物質であり
、遊離の状態では水に難溶である為に通常ナトリウム塩
が用いられている。Ampicillin is a commonly used antibiotic worldwide, and because it is sparingly soluble in water in its free form, its sodium salt is usually used.
しかもアンピシリンナトリウム塩は水溶液とした時には
不安定である為に用時調製せざるを得すアンピシリンナ
トリウム塩の結晶もしくは粉末と溶解液をそれぞれ別個
に調製するいわゆる粉末注射剤の形態が採用されている
。Moreover, since ampicillin sodium salt is unstable when made into an aqueous solution, it has to be prepared at the time of use.A so-called powder injection form is adopted in which crystals or powder of ampicillin sodium salt and a solution are prepared separately. .
粉末注射剤の備えなければならない性質としては使用直
前まで安定に保存され得ることは勿論であるが、用時溶
解液例えば生理食塩水あるいは注射用蒸留水等にすみや
かに溶解し、不溶物の残存しないことが必要であり、そ
のような製剤が診療の迅速化、操作の簡素化等の面から
強く要望されている。The properties that powder injections must have include being able to be stored stably until just before use, but also being able to dissolve quickly in a solution such as physiological saline or distilled water for injection before use, and to avoid the presence of residual insoluble matter. There is a strong demand for such preparations from the viewpoint of speeding up medical treatment and simplifying operations.
しかし、現在一般に用いられている公知のアンピシリン
ナトリウム塩の粉末注射薬の場合は、たとえ溶解液を加
えてもそのまま放置しては極端に溶解がおくれ、いちい
ちふりまぜてもその溶解に15秒以上を要するものが多
い。However, in the case of the well-known ampicillin sodium salt powder injection currently in general use, even if a solution is added, dissolution is extremely slow if left as is, and even if you shake it one by one, it takes more than 15 seconds to dissolve. There are many things that require
これを解決しようとして凍結乾燥を行う方法も考えられ
るが、凍結乾燥製剤の場合は溶解はすみやかでも微量の
不溶分を生成することがあるので好ましくない。A method of freeze-drying may be considered in an attempt to solve this problem, but in the case of freeze-dried preparations, although they dissolve quickly, they may produce trace amounts of insoluble matter, which is not preferable.
又、粉末もしくは結晶粒子の微細化によって溶解し易い
製品を得る方法も考えられるがアンピシリンナトリウム
塩の場合は微細化により逆に溶解速度が低下する。Another possible method is to obtain a product that is easily soluble by making the powder or crystal grains finer, but in the case of ampicillin sodium salt, the dissolution rate decreases due to finer particles.
これは一部の溶解したアンピシリンナトリウム塩が被膜
状となって表面を覆うためと考えられる。This is considered to be because some of the dissolved ampicillin sodium salt forms a film and covers the surface.
本発明者等はこれらの欠点を除き水にすみやかに溶ける
アンピシリンナトリウム塩を得るために種々研究の結果
、従来室温もしくはそれ以下(例えば特公昭46−93
42号では15〜25℃、英国特許1212798号で
は0〜5°C)で行われ、しかもその際0.2%以上の
含水塩化メチレン中でアンピシリントリエチルアミン塩
を経由してナトリウム塩を生成させた場合には充分高い
効力を示すものが得られない(特公昭46−9342号
公報参照)とされていたにも拘らず28〜40℃におい
て0.2%以上の含水塩化低級アルキレン中ジイソプロ
ピルアミン塩を経由して製した場合予想外に効力を維持
しながら、かつ水に対する溶解度が高く、高純度にして
p取、遠心分離等による単離の容易なアンピシリンナト
リウム塩の得られることを見出した。The present inventors have conducted various studies to eliminate these drawbacks and obtain ampicillin sodium salt that dissolves quickly in water.
In No. 42, the temperature was 15 to 25 °C; in British Patent No. 1,212,798, it was 0 to 5 °C), and the sodium salt was generated via ampicillin triethylamine salt in 0.2% or more aqueous methylene chloride. Although it was said that in some cases, it was not possible to obtain a substance showing sufficiently high efficacy (see Japanese Patent Publication No. 46-9342), diisopropylamine salt in lower alkylene chloride containing 0.2% or more of water at 28 to 40°C. It has been found that ampicillin sodium salt can be obtained which unexpectedly maintains its efficacy, has high solubility in water, and is highly purified and easily isolated by purification, centrifugation, etc.
本発明による時は粉末注射薬とした場合、投与前溶解液
を加えると特にふりまぜたすせずども10秒以内に完全
に溶解するので診療の際に極めて有利である。According to the present invention, when a powder injection drug is prepared, it is completely dissolved within 10 seconds without stirring, especially when a dissolving solution is added before administration, which is extremely advantageous in medical treatment.
本発明を実施するにはアンピシリンの無水物あるいは一
〜三水和物を塩化低級アルキレン例えば塩化メチレン、
塩化エチレン、クロロホルム等に分散懸濁させ等モルな
いしやや過剰のジイソプロピルアミンを加えてアンピシ
リンのジイソプロピルアミン塩を生成させる。In carrying out the present invention, ampicillin anhydride or mono- to trihydrate may be used in combination with a lower alkylene chloride, such as methylene chloride,
The diisopropylamine salt of ampicillin is produced by dispersing and suspending it in ethylene chloride, chloroform, etc. and adding equimolar to slightly excess diisopropylamine.
この際無水のアンピシリンを用いた時にはアンピシリン
イソプロピルアミン塩溶液の含水量が0.2〜:1.、
OW/W%となる様に水を加えて溶解させる。At this time, when anhydrous ampicillin is used, the water content of the ampicillin isopropylamine salt solution is 0.2 to 1. ,
Add water to dissolve in OW/W%.
又、アンピシリンの水和物を用いた時には無水硫酸ナト
リウム、無水硫酸マグネシウム、モレキュラーシーブ等
の脱水剤を用いて含水量を0.2〜1.0 W/W%に
調整するとよい。Further, when a hydrate of ampicillin is used, the water content may be adjusted to 0.2 to 1.0 W/W% using a dehydrating agent such as anhydrous sodium sulfate, anhydrous magnesium sulfate, or molecular sieve.
ここに得られたアンピシリンジイソプロピルアミン塩溶
液をナトリウム塩に変換するには溶液をやや加温好まし
くは28〜40℃に加温し2−エチルヘキサン酸ナトリ
ウムを加えればよい。In order to convert the ampicillin diisopropylamine salt solution obtained here into the sodium salt, the solution may be slightly heated, preferably at 28 to 40°C, and sodium 2-ethylhexanoate may be added thereto.
反応温度を26℃以下とするときは結晶粒子が微細とな
るので好ましくない。It is not preferable to set the reaction temperature to 26° C. or lower because the crystal particles become fine.
2−エチルヘキサン酸ナトリウムは通常n−酢酸ブチル
、n−ブタノール、塩化メチレン等の有機溶媒の溶液と
して用いられる。Sodium 2-ethylhexanoate is usually used as a solution in an organic solvent such as n-butyl acetate, n-butanol, or methylene chloride.
これらの溶媒は単一もしくは混合して用いられるが、塩
化メチレンの場合は混合溶媒が殊に好適である。These solvents may be used singly or in combination, and in the case of methylene chloride, a mixed solvent is particularly suitable.
ここに生成したアンピシリンナトリウム塩は直ちにある
いはしばらく放置した後に沢取あるいは遠心分離するこ
とによって単離される。The ampicillin sodium salt produced here can be isolated immediately or after being left for a while and then filtered or centrifuged.
単離された生成物は不溶性の溶媒例えば塩化メチレン等
で洗浄した後乾燥される。The isolated product is washed with an insoluble solvent such as methylene chloride and then dried.
洗浄に際して少量のジイソピロピルアミン等を洗液に加
えることは副生ずる2−エチルヘキサン酸を除くのに好
適である。Adding a small amount of diisopropylamine or the like to the washing liquid during washing is suitable for removing by-product 2-ethylhexanoic acid.
得られたアンピシリンナトリウム塩は例えば特公昭46
−9342号方法の場合は2μの大きさであるに対し、
その粒子の大きさが2〜5μ×25〜125μの棒状で
あり、単離が容易である。The obtained ampicillin sodium salt is, for example,
In the case of method No. 9342, the size is 2μ, whereas
The particle size is rod-shaped with a size of 2 to 5 microns x 25 to 125 microns, and isolation is easy.
そして粒子が大きいにも拘らず粉末注射薬とした際には
速やかに溶解し、不溶分を残さない。Even though the particles are large, when made into a powder injection, it dissolves quickly and leaves no insoluble matter.
以下に本発明によって得られたアンピシリンナトリウム
塩と特公昭46−9342号方法によって得られた製品
との溶解速度を比較した実験及びその結果を示す。The following is an experiment comparing the dissolution rate of ampicillin sodium salt obtained according to the present invention and a product obtained by the method of Japanese Patent Publication No. 46-9342, and the results thereof.
実験1
アンピシリンナトリウム塩の結晶400m9を高さ4.
5CfrL 内径2.5cIrLの円筒型ガラスびんに
秤取し、器底を軽く3回叩き表面をならした後、蒸留水
1.2mlを器壁沿いに静かに加え5秒間振盪(振盪数
17回、振幅10CrrL)シて観察する。Experiment 1 A 400 m9 crystal of ampicillin sodium salt was grown at a height of 4.
5CfrL Weighed into a cylindrical glass bottle with an inner diameter of 2.5cIrL, and after lightly tapping the bottom of the bottle three times to smooth the surface, gently added 1.2ml of distilled water along the wall of the vessel and shook for 5 seconds (shaking number 17 times, Observe with an amplitude of 10 CrrL).
不溶の際は新たに試料を調製して同様に10秒間振盪す
る。If it is not dissolved, prepare a new sample and shake it for 10 seconds in the same way.
同様な方法で5秒間隔で振盪時間を延長して観察する。In the same manner, the shaking time is extended at 5 second intervals and observed.
本願方法 5秒 溶解特公昭46
−9342号方法 15秒 不溶20秒 溶解
実験2
アンピシリンナトリウム塩の結晶400m9を高さ5.
5(X 内径]、、5cmの円筒型ガラスびんに秤取し
、器底を軽く10回叩き表面をならした後、蒸留水1.
2mlを器壁沿いに静かに加え結晶が水と接触してから
完全に溶解するまでの時間を観察する。Method of application 5 seconds Melting Special Publication 1977
-9342 method 15 seconds Insoluble 20 seconds Dissolution experiment 2 A crystal of ampicillin sodium salt of 400 m9 was placed at a height of 5.
5 (inner diameter), weighed into a 5 cm cylindrical glass bottle, lightly tapped the bottom 10 times to smooth the surface, and then poured 1.
Gently add 2 ml along the vessel wall and observe the time from when the crystals come into contact with the water until they are completely dissolved.
本願方法 5〜20秒特公昭46
−9342号方法 4〜5 秒以下に本発明の実施例
を示すが実施例中のアンピシリンナトリウム塩の純度は
予防衛生研究新製「常用標準アンピシリン」を標準とし
、その純度を100%としてヨウ素法によって求めた。Method of application: 5 to 20 seconds
Method No. 9342 Examples of the present invention will be shown below for 4 to 5 seconds. The purity of ampicillin sodium salt in the examples is determined by the iodine method using Preventive Health Research Shin's "commonly used standard ampicillin" as the standard, and assuming that the purity is 100%. It was found by
実施例 1
アンピシリン三水和物3.22S’と無水硫酸ナトリウ
ム3グとを塩化メチレン32TLl中に懸濁させジイソ
プロピルアミン1.21:l’を加えて25°Cで30
分間かきまぜた後沢過する。Example 1 3.22 S' of ampicillin trihydrate and 3 g of anhydrous sodium sulfate were suspended in 32 TL of methylene chloride, and 1.21:1 of diisopropylamine was added thereto for 30 min at 25°C.
Stir for a minute and then strain.
硫酸ナトリウムは塩化メチレン27m1で洗浄し涙液と
洗液とを合する。The sodium sulfate is washed with 27 ml of methylene chloride, and the lachrymal fluid and washing solution are combined.
得られた塩化メチレン溶液(含水量0.3%)を30℃
に加温し35W/W%2−エチルヘキサン酸ナトリウム
酢酸ブチル溶液3.99S’と酢酸ブチル7mlとの泥
液をかきまぜながら30分間で滴下する。The obtained methylene chloride solution (water content 0.3%) was heated at 30°C.
A slurry of 35 W/W % sodium 2-ethylhexanoate in butyl acetate (3.99 S') and 7 ml of butyl acetate was stirred and added dropwise over 30 minutes.
滴下後1時間放置した後結晶を沢取し5%ジイソプロピ
ルアミン塩化メチレン溶液及び塩化メチレンで順次洗浄
し45℃で窒素気流中で通風乾燥するとアンピシリンナ
トリウム塩を得る。After the dropwise addition, the crystals were left to stand for 1 hour, and the crystals were collected, washed successively with a 5% diisopropylamine methylene chloride solution and methylene chloride, and dried with ventilation at 45° C. in a nitrogen stream to obtain ampicillin sodium salt.
収率88% 純度101.8%
実施例 2
アンピシリン三水和物3.22Pと無水硫酸ナトリウム
31とを塩化メチレン22m1中に懸濁させジイソプロ
ピルアミン1.212Pを加えて25℃で20分間かき
まぜた後沢過する。Yield 88% Purity 101.8% Example 2 Ampicillin trihydrate 3.22P and anhydrous sodium sulfate 31 were suspended in 22ml of methylene chloride, diisopropylamine 1.212P was added, and the mixture was stirred at 25°C for 20 minutes. Gosawa passes.
硫酸ナトリウムは塩化メチレン5TLlで洗浄しF液と
洗液とを合する。The sodium sulfate is washed with 5 TL of methylene chloride, and the F solution and the washing solution are combined.
得られた塩化メチレン溶液(含水量0.5%を36℃に
加温し35W/W%2−エチルヘキサン酸ナトリウム酢
酸ブチル溶液3.99f?と酢酸ブチル7mlとの混液
をかきまぜながら20分間で滴下する。The obtained methylene chloride solution (water content 0.5%) was heated to 36°C and mixed with 3.99 f? of 35 W/W% sodium 2-ethylhexanoate butyl acetate solution and 7 ml of butyl acetate for 20 minutes while stirring. Drip.
滴下後析出した結晶を沢取し5%ジイソプロピルアミン
塩化メチレン溶液及び塩化メチレンで順次洗浄し常温で
減圧乾燥チるとアンピシリンナトリウム塩を得る。After dropping, the precipitated crystals were collected, washed successively with a 5% diisopropylamine methylene chloride solution and methylene chloride, and dried under reduced pressure at room temperature to obtain ampicillin sodium salt.
収率87.8% 純度101.9%
実施例 3
アンピシリン三水和物644グと無水硫酸ナトリウム6
?とを塩化メチレン30m1中に懸濁させジイソプロピ
ルアミン2.424Pを加えて25°Cで30分間かき
まぜた後沢過する。Yield 87.8% Purity 101.9% Example 3 Ampicillin trihydrate 644 g and anhydrous sodium sulfate 6
? was suspended in 30 ml of methylene chloride, 2.424 P of diisopropylamine was added, stirred at 25°C for 30 minutes, and then filtered.
硫酸ナトリウムは塩化メチレン10m1で洗浄し泥液と
洗液とを合する。The sodium sulfate was washed with 10 ml of methylene chloride, and the mud and washing liquid were combined.
得られた塩化メチレン溶液を32°Cに加温し35W/
W%2−エチルヘキサン酸ナトリウム酢酸ブチル溶液7
.98Pと塩化メチレン7mlとの泥液をかきまぜなが
ら20分間で滴下する。The obtained methylene chloride solution was heated to 32°C and 35W/
W% Sodium 2-ethylhexanoate butyl acetate solution 7
.. A slurry of 98P and 7 ml of methylene chloride is added dropwise over 20 minutes while stirring.
滴下後2時間水冷下(約20°C)に放置した後に析出
した結晶を沢取し5%ジイソプロピルアミン塩化メチレ
ン溶液及び塩化メチレンで順次洗浄し45°Cで窒素気
流中で乾燥するとアンピシリンナトリウム塩を得る。After the dropwise addition, the precipitated crystals were left in water cooling (approximately 20°C) for 2 hours, washed sequentially with a 5% diisopropylamine methylene chloride solution and methylene chloride, and dried in a nitrogen stream at 45°C to obtain ampicillin sodium salt. get.
収率87.5% 純度98.8%実施例 4
無水アンピシリン13.955’を塩化メチレン160
m1中に懸濁させ、ジイソプロピルアミン6.06Pを
加えて25℃で20分間かきまぜた後沢過する。Yield 87.5% Purity 98.8% Example 4 13.955' of anhydrous ampicillin was dissolved in methylene chloride 160
ml, add 6.06P of diisopropylamine, stir at 25°C for 20 minutes, and then filter.
使用した器具類は塩化メチレン135m1で洗浄しf液
と洗液とを合する。The instruments used were washed with 135 ml of methylene chloride, and the f solution and washing solution were combined.
得られた塩化メチレン溶液に水0.88m1を加えて溶
解させる(含水量0.2%)。Add 0.88 ml of water to the obtained methylene chloride solution to dissolve it (water content 0.2%).
ついで35℃に加温し35W/W%2−エチルヘキサン
酸ナトリウム酢酸ブチル溶液207を酢酸ブチル40m
1との混液を40分間で滴下する。Then, it was heated to 35°C and 35W/W% sodium 2-ethylhexanoate butyl acetate solution 207 was mixed with 40ml of butyl acetate.
A mixture of 1 and 1 was added dropwise over 40 minutes.
滴下後析出した結晶を沢取し5%ジイソプロピルアミン
塩化メチレン溶液及び塩化メチレンで順次洗浄し45℃
で窒素気流中で乾燥するとアンピシリンナトリウム塩を
得る。After dropping, the precipitated crystals were collected and washed sequentially with 5% diisopropylamine methylene chloride solution and methylene chloride at 45°C.
Drying in a nitrogen stream yields ampicillin sodium salt.
収率8.7% 純度101.9%
実施例 5
無水アンピシリン13.95Pを塩化メチレン160m
1中で懸濁させジイソプロピルアミン6.06Pを加え
て25℃で20分間かきまぜた後沢過する。Yield 8.7% Purity 101.9% Example 5 Anhydrous ampicillin 13.95P was dissolved in methylene chloride 160m
1, add 6.06 P of diisopropylamine, stir at 25°C for 20 minutes, and then filter.
器具類は塩化メチレン50m1で洗浄し泥液と洗液とを
合する。The instruments were washed with 50 ml of methylene chloride, and the mud and washing liquid were combined.
得られた塩化メチレン溶液に水18m1を加えて溶解さ
せる(含水量0.6%尤ついで38°Cに加温し35W
/W%2−エチルヘキサン酸す) IJウム酢酸ブチル
溶液20′?と酢酸ブチル40TILlとの混液を20
分間で滴下する。Add 18 ml of water to the obtained methylene chloride solution and dissolve it (water content 0.6%, then warm to 38 ° C and 35 W
/W% 2-ethylhexanoate) IJum butyl acetate solution 20'? and 40 TILl of butyl acetate.
Drip in minutes.
滴下後析出した結晶を沢取し5%ジイソプロピルアミン
塩化メチレン溶液及び塩化メチレンで順次洗浄し45℃
で窒素気流中で乾燥するとアンピシリンナトリウム塩を
得る。After dropping, the precipitated crystals were collected and washed sequentially with 5% diisopropylamine methylene chloride solution and methylene chloride at 45°C.
Drying in a nitrogen stream yields ampicillin sodium salt.
収率87% 純度101.8%Yield 87% Purity 101.8%
Claims (1)
ピルアミン塩塩化低級アルキレン溶液と2−エチルヘキ
サン酸す) IJウムとを28〜40℃で反応させるこ
とを特徴とするアンピシリンナトリウム塩の製法。1. A method for producing ampicillin sodium salt, which comprises reacting a lower alkylene chloride solution of ampicillin diisopropylamine salt having a water content of 0.2 to 1.0% with 2-ethylhexanoic acid at 28 to 40°C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48130502A JPS5817728B2 (en) | 1973-11-20 | 1973-11-20 | Ampicillin Sodium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP48130502A JPS5817728B2 (en) | 1973-11-20 | 1973-11-20 | Ampicillin Sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5077524A JPS5077524A (en) | 1975-06-24 |
| JPS5817728B2 true JPS5817728B2 (en) | 1983-04-09 |
Family
ID=15035792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP48130502A Expired JPS5817728B2 (en) | 1973-11-20 | 1973-11-20 | Ampicillin Sodium |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5817728B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1209477A (en) * | 1981-03-26 | 1986-08-12 | Bruce E. Haeger | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
| CN100384854C (en) * | 2004-03-12 | 2008-04-30 | 河北张药股份有限公司 | A kind of preparation method of ampicillin sodium |
| CN103880863B (en) * | 2014-03-27 | 2015-10-28 | 哈药集团制药总厂 | A kind of preparation method of ampicillin |
-
1973
- 1973-11-20 JP JP48130502A patent/JPS5817728B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5077524A (en) | 1975-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5463116A (en) | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them | |
| CA2114678C (en) | Crystals of n-(trans-4-isopropylcyclohexylcarbonyl)- d-phenylalanine and methods for preparing them | |
| JPS5944391A (en) | Novel cefuroxime ester | |
| JPH09504535A (en) | Novel benzoylguanidine derivatives, their preparation and use in pharmaceutical compositions | |
| KR900001422B1 (en) | Anhydrous crystalline sodium salt of 5-chloro-3- (2-tenoyl) -2-oxindole-1-carboxamide | |
| JPS5817728B2 (en) | Ampicillin Sodium | |
| CN101223135A (en) | Preparation of Paricalcitol | |
| RU2539576C2 (en) | Method for preparing complex of gadobenate dimeglumine in solid form | |
| CN109776372A (en) | Vildagliptin related substances and preparation method thereof | |
| CN116813675B (en) | Compound crystal form and preparation, composition and application thereof | |
| US4219641A (en) | Process for preparing erythromycin succinate | |
| CN101759708B (en) | Cefodizime sodium crystal form and preparation method thereof as well as drug compound comprising crystal form | |
| US3932490A (en) | Doxycycline aceturate | |
| SU583759A3 (en) | Method of preparing penicillins or their salts or hydrated forms | |
| CN104151324A (en) | Method for preparing ampicillin sodium by menstruum crystallization method | |
| EP1086109A1 (en) | Process for preparing crystalline salts of amoxycillin | |
| JPS6163695A (en) | Purimycin salt, manufacture and medicinal composition | |
| US2439720A (en) | Process of producing sodium tetrathionate | |
| CN106432090B (en) | A kind of crystal form and its preparation method and application of deuterated imidazoquinolone compounds | |
| JPH05508652A (en) | Novel salts derived from 26-(dialkylaminoalkylsulfonyl)pristinamycin IIB | |
| CN106928228A (en) | Ao Gelieting salt and its crystal formation, their preparation method and pharmaceutical composition | |
| US3976646A (en) | Process for preparing equimolecular salt of piperazine and 1,2-diphenyl-4-butyl-3,5-dioxo pyrazolidine | |
| US3784562A (en) | Methyl acetoacetic ester enamine of d-2-(1,4-cyclohexadien-1-yl)glycine, sodium salt-dimethylformamide adduct | |
| SA06270303B1 (en) | new crystalline modification lopinavir | |
| US20020137926A1 (en) | Process for preparing crystalline salts of amoxycillin |